A group sequential response-adaptive randomized double-blinded clinical trial to evaluate the safety and efficacy of add-on olanzapine plus pregabalin for the prevention of chemotherapy-induced nausea and vomiting.
Saved in:
| Title: | A group sequential response-adaptive randomized double-blinded clinical trial to evaluate the safety and efficacy of add-on olanzapine plus pregabalin for the prevention of chemotherapy-induced nausea and vomiting. |
|---|---|
| Authors: | Ramasubbu MK; Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India., Hota D; Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India., Das Majumdar SK; Department of Radiation Oncology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India., Parida DK; Department of Radiation Oncology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India., Mukherjee P; Department of Radiation Oncology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India., Srinivasan A; Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India. anandsrinivasan@aiimsbhubaneswar.edu.in. |
| Source: | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2025 Feb 19; Vol. 33 (3), pp. 203. Date of Electronic Publication: 2025 Feb 19. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
